NCT02072031 Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma(RCC) Status UNKNOWN Phase PHASE2
NCT02029209 To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer Status UNKNOWN Phase PHASE2/PHASE3
NCT01924195 Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer(ALTER0302) Status COMPLETED Phase PHASE2
NCT01833923 A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics Status COMPLETED Phase PHASE1